Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Jonnyboy85on Apr 05, 2021 12:38am
128 Views
Post# 32935945

RE:RE:RE:RE:Let me help you out with that

RE:RE:RE:RE:Let me help you out with thatDaw stinkyscoutP, if you keep tryharding this bashing thing you're going to give yourself a stroke. A lot of websites will drop analyst forecasts after 3 months, some after 6 months etc etc. They usually get replaced with an algorithmic one or simply a placeholder. The way things work is the analyst only updates a rating if they need to, so up until now Noel has been satisfied with his rating and nothing materially changed since his last rating so he hasn't updated it. Now we have a good deal of changes and we should see a new one but who knows, he could still think its good and not change a thing, he'll he may have already known about this partner and none of this is new to him at all, so again it might not get updated. And even if he does update it's anyone's guess ay this point what that will be. One thing is for sure though, it's most certainly not 1.60 currently lol but if you really want to keep this up, I can find about 10 different "ratings" for szls around the internet that range anywhere from where we are now to $4 and higher but again none of them are valid because none of them are our analyst Noel Atkinson.
Jonnyboy85 wrote:
Jonnyboy85 wrote: I understand that you're both missing the point intentionally, but just for fun I'll explain. See, Noel is our ONLY analyst, and that is our ONLY analyst rating despite your attempts to portray it otherwise. And you're right, when things change usually the analyst will update their rating.


Now that you have the CORRECT source, with the CORRECT rating of $4.00, by the person who has more information about our company than anyone, and more education when it comes to investing than anyone who has ever posted here, you can follow along when he makes his next update with the rest of us:) 


and just in case you missed it the first time,

https://www.tipranks.com/analysts/noel-atkinson





<< Previous
Bullboard Posts
Next >>